Drug-induced sprue-like intestinal disease

International Journal of Celiac Disease

Volumn 2, Issue 2, 2014, Pages 49-53

  Freeman, Hugh James ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Celiac disease; Drug induced small intestinal disease; Post colectomy enteritis; Sprue like enteropathy; Sprue like intestinal disease; Unclassified sprue

Indexed keywords

EID: 85010645243     PISSN: 23343427     EISSN: 23343486     Source Type: Journal    
DOI: 10.12691/ijcd-2-2-5     Document Type: Article

References (34)

1. Freeman HJ, Chopra A, Clandinin MT, Thomson AB. Recent advances in celiac disease. World J Gastroenterol 2011; 17: 2259-2272.
2. Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol 2012; 18: 6036-6059.
3. Freeman HJ. Pearls and pitfalls in the diagnosis of adult celiac disease. Can J Gastroenterol 2008; 22: 273-280.
4. MacDonald WC, Brandborg LL, Flick AL, Trier JS, Rubin CE. Studies of celiac sprue. IV. The response of the whole length of the small intestine to a gluten-free diet. Gastroenterology 1964; 47: 573-589.
5. Tursi A, Brandimarte G, Giorgetti GM, Elisei W, Inchingolo CD, Monardo E, Aiello F. Endoscopic and histologic findings in the duodenum of adults with celiac disease before and after changing to a gluten-free diet: a 2-year prospective study. Endoscopy 2006; 38: 702-707.
6. Freeman HJ. Sprue-like intestinal disease. International Journal of Celiac Disease 2014; 2: 6-10.
7. Marcos LA, Gotuzzo E. Intestinal protozoan infections in the immunocompromised host. Curr Opin Infect Dis 2013; 26: 295-301.
8. Washington K, Stenzel TT, Buckley RH, Gottfried MR. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol 1996; 20: 1240-1252.
9. Agarwal S, Mayer L. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol 2013; 11: 1050-1063.
10. Gooding IR, Springall R, Talbot IC, Silk DB. Idiopathic small intestinal inflammation after colectomy for ulcerative colitis. Clin Gastroenterol Hepatol 2008; 6: 707-709.
11. Rosenfeld G, Freeman HJ, Brown M, Steinbrecher UP. Severe and extensive enteritis following colectomy for ulcerative colitis. Can J Gastroenterol 2012; 26: 866-867.
12. Robinson JW. Intestinal malabsorption in the experimental animal. Gut 1972; 13: 938-945.
13. Wilson FA, Hoyumpa AM Jr. Ethanol and small intestinal transport. Gastroenterology 1979; 76: 388-403.
14. Longstreth GF, Newcomer AD. Drug-induced malabsorption. Mayo Clin Proc 1975; 50: 284-293.
15. Jacobson ED, Prior JT, Faloon WW. Malabsorptive syndrome induced by neomycin: morphologic alterations in the jejunal mucosa. J Lab Clin Med 1960; 56: 245-250.
16. Race TF, Paes IC, Faloon WW. Intestinal malabsorption induced by oral colchicine. Comparison with neomycin and cathartic agents. Am J Med Sci 1970; 259: 32-41.
17. Wright N, Watson A, Morley A, Appleton D, Marks J, Douglas A. The cell cycle time in the flat (avillous) mucosa of the human small intestine. Gut 1973; 14: 603-606.
18. Trier JS. Morphologic alterations induced by methotrexate in the mucosa of the human proximal intestine. 1. Serial observations by light microscopy. Gastroenterology 1962; 42: 295-305.
19. Roche AC, Bognel JC, Bognel C, Bernier JJ. Correlation between the histological changes and glucose intestinal absorption following a single dose of 5 fluorouracil. Digestion 1970; 3: 195-212.
20. Freeman HJ. Sulindac associated small bowel lesion. J Clin Gastroenterol 1986; 8: 569-571.
21. Ziegler TR, Fernandez-Estivariz C, Gu LH, Fried MW, Leader LM. Severe villous atrophy and chronic malabsorption induced by azothioprine. Gastroenterology 2003; 124: 1950-1957.
22. Ducloux D, Ottignon Y, Semhoun-Ducloux S, Labbe S, Saint-Hillier Y, Miguet JP, Carayon P, Chalopin JM. Mycophenolate mofetil-induced villous atrophy. Transplantation 1998; 66: 1115-1116.
23. Kamar N, Faure P, Dupuis E, Cointault O, Joseph-Hein K, Durand D, Moreau J, Rostaing L. Villous atrophy induced by mycophenolate mofetil in renal-transplant patients. Transpl Int 2004; 17: 463-467.
24. Tapia O, Villaseca M, Sierralta A, Roa JC. Duodenal villous atrophy associated with Mycophenolate mofetil: report of one case. Rev Med Chil 2010; 138: 590-594.
25. Parfitt JR, Jayakumar S. Driman DK. Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol 2008; 32: 1367-1372.
26. Freeman HJ. Collagenous mucosal inflammatory diseases of the gastrointestinal tract. Gastroenterology 2005; 129: 338-350.
27. Freeman HJ. Long-term natural history and complications of collagenous colitis. Can J Gastroenterol 2012; 26: 627-630.
28. Rubio-Tapia A, Herman ML, Ludvigsson JF, et al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc 2012; 87: 732-738.
29. Tran TH, Li H. Olmesartan and drug-induced enteropathy. PT 2014; 39: 47-38.
30. Dreifuss SE, Tomizawa Y, Farber NJ, Davison JM, Sohnen AE. Spruelike enteropathy associated with olmesartan: an unusual case of severe diarrhea. Case Rep Gastrointest Med 2013; 2013: 618071.
31. Nielsen JA, Steephen A, Lewin M. Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug. World J Gastroenterol 2013; 19: 6928-6930.
32. DeGaetani M, Tennyson CA, Lebwohl B, Lewis SK, Abu Daya H, Arguelles-Grande C, Bhagat G, Green PH. Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma. Am J Gastroenterol 2013; 108: 647-653.
33. Freeman HJ. Colitis associated with biological agents. World J Gastroenterol 2012; 18: 1871-1874.
34. Gentile NM, D'Souza A, Fujii LL, Wu TT, Murray JA. Association between ipilimumab and celiac disease. Mayo Clin Proc 2013; 88: 414-417.